Upal Basu Roy, Executive Director of Research at LUNGevity Foundation, shared about a Facebook Live event hosted by LUNGevity Foundation. Read his post on LinkedIn below:
“Are you interested in learning about EGFR-positive non-small cell lung cancer?
Please join me for a Facebook Live event hosted by LUNGevity Foundation that explores how immune cells can be engineered to target EGFR+ NSCLC.
- Date: Thursday, October 10
- Time: 12 PM Eastern Time
- Where: Tune in here
Joining me will be Jill Feldman and Laura Book from the EGFR Resisters, along with Alexandre Reuben, PhD from the MD Anderson Cancer Center. Dr. Reuben received a 2023 EGFR Resisters/LUNGevity Foundation grant.
I hope to see you there!”